EZH2 and liver cancer: EZH2 has been unraveled as a core factor in hepatocarcinogenesis, self-renewal of liver cancer stem cells (CSCs), and molecular targeted therapy (Cheng et al., 2011; Zhu et al., 2016; Xiao et al., 2019).